Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Research Services
Australia New Zealand runs a Research Services operation from Camperdown, NSW. Ownership is a nonprofit; it publishes at anzgog.org.au. It holds two addresses on record, all in Australia. The record counts 28 people. Tagged oncology, research and women's health. The record links nine similar brands, most of them in Research Services.
ANZGOG is the peak, national gynaecological cancer research organisation for Australia and New Zealand.
Our mission is to improve outcomes and quality of life for everyone with a lived experience of gynaecological cancer by conducting and promoting clinical trials and multidisciplinary research.
#AdvancingResearchSavingLives
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
The record holds 28 counted staff profiles at January 2026, inside the self-reported 11–50 band.
Two addresses on record, Australia only. Primary: 119-143 Missenden Road, Level 6, CAMPERDOWN, NSW 2050.
None linked to this brand.
Ten tags on the brand's own list, among them oncology, research and women's health.
15 profiles list Australia New Zealand Gynaecological Oncology Group (ANZGOG) as a peer. It lists ten peers of its own. COGNO - Cooperative Trials Group for Neuro-Oncology and Queensland Centre for Gynaecological Cancer Research list it back.